The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Boston Scientific to Participate in 30th Annual J.P. Morgan Healthcare Conference

Tuesday, January 03, 2012

Boston Scientific to Participate in 30th Annual J.P. Morgan Healthcare Conference13:30 EST Tuesday, January 03, 2012NATICK, Mass., Jan. 3, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 30th Annual J.P. Morgan Healthcare Conference in San Francisco.Hank Kucheman, Chief Executive Officer, will make a presentation about the Company on Wednesday, January 11, 2012, beginning at approximately 8:30 a.m. Pacific Time.  Following the presentation, Mike Mahoney, President, and Jeff Capello, Executive Vice President and Chief Financial Officer, will join Mr. Kucheman in a question and answer session.A live webcast of the presentation and question and answer session will be available to all interested parties via Boston Scientific's website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.This webcast is being hosted by J.P. Morgan.  The replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.   CONTACT:Eric Olson 336-293-4393 (office) Media Relations Boston Scientific Corporation eric.olson@bsci.com   Sean Findlen 617-520-7268 (office) Media Relations Weber Shandwick sfindlen@webershandwick.com   Sean Wirtjes (508) 652-5305 (office) Investor Relations Boston Scientific Corporation investor_relations@bsci.comSOURCE Boston Scientific Corporation